News
ZOM
0.2804
-3.71%
-0.0108
BRIEF-ZomInc, Zomedica Enters Into Related Agreements With Qorvo Biotechnologies
Reuters · 01/24 11:16
Zomdica On January 17 Along With Unit, Zominc And Zomedica Entities Entered Into Three Related Agreements With Qorvo Biotechnologies Including Transition And Support Agreement, BAW Sensor Supply Agreement, Development And Manufacturing License Agreement
Benzinga · 01/24 11:12
PRTY Stock Alert: NYSE Halts Trading in Party City Amid Bankruptcy News
Investor Place · 01/18 16:07
Why Is Zomedica (ZOM) Stock Up Today?
Investor Place · 01/18 14:53
Zomedica Soars on Truforma Restructuring; Street Sees 20x Upside
TipRanks · 01/18 12:58
Zomedica stock rises ~15% on taking control of Truforma products via licesing deal
Seeking Alpha · 01/18 11:29
Zomedica To Take Control Of Aspects Of TRUFORMA Product Line Previously Provided By Qorvo
Benzinga · 01/18 11:02
Zomedica, Structured Monitoring to start selling remote monitoring system VetGuardian
Seeking Alpha · 01/17 11:33
Zomedica Announced Expanded Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors
Benzinga · 01/17 11:13
Zomedica: High Risk High Reward Play In Veterinary Supplies
Seeking Alpha · 01/10 00:02
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 01/06 18:16
Dawson James Initiates Coverage On Zomedica with Buy Rating, Announces Price Target of $6
Benzinga · 01/06 13:25
--Dawson James Starts Zomedica Pharmaceuticals at Buy With $6 Price Target
--Dawson James Starts Zomedica Pharmaceuticals at Buy With $6 Price Target
MT Newswires · 01/06 10:10
Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans
Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announces an update interview with the Wall Street Analyzer, and Larry Heaton, Zome...
ACCESSWIRE · 12/15/2022 11:30
Zomedica GAAP EPS of -$0.005, revenue of $4.78M
Seekingalpha · 11/14/2022 23:28
Zomedica Pharmaceuticals Q3 EPS $(0.01), Sales $4.78M Up From $22.51K YoY
Benzinga · 11/14/2022 21:53
Zomedica Granted U.S. Patent #11486878 Compositions and Methods for Identifying Cancer Cells
Benzinga · 11/01/2022 11:49
Zomedica To Present at Dawson James Securities 7th Annual Small Cap Growth Conference
Zomedica Corp. (NYSE American:ZOM) announced today that Larry Heaton, Zomedica's Chief Executive Officer, is scheduled to provide a company overview and its prospects for growth at the Dawson James Securities Small Cap Growth Conference on October 12, 2022...
ACCESSWIRE · 09/28/2022 10:30
Zomedica Announces Designation of PulseVet® System as the Official Shock Wave Therapy of the National Cutting Horse Association
Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for equine and companion animals, is pleased to announce that the PulseVet system has been named the Official Shock W...
ACCESSWIRE · 09/06/2022 10:30
Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket
Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss.
Benzinga · 08/23/2022 11:36
More
Webull provides a variety of real-time ZOM stock news. You can receive the latest news about Zomedica Corp through multiple platforms. This information may help you make smarter investment decisions.
About ZOM
Zomedica Corp. is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. The Company is developing point-of-care diagnostic platform, which is based on miniaturized laser-based Raman spectroscopy technology and is designed to detect pathogens in companion animals. Its product portfolio includes diagnostics and therapeutic medical devices that emphasize patient health. It offers TRUFORMA is a diagnostic biosensor platform and the first five assays for the detection of thyroid disorders in dogs and cats and adrenal disorders in dogs. The TRUFORMA platform uses bulk acoustic wave (BAW) technology to provide a non-optical and fluorescence free detection system for use at the point-of-care. The TRUFORMA also offers complete control over the testing process and allow veterinarians to make clinical decisions. PulseVet platform provides treatment for musculoskeletal issues in horses and small animals.